Guests: William Haseltine Chairman, Chief Executive Officer, Human Genome Sciences, Inc. Rockville, Maryland Joshua Labaer Director, Institute of Proteomics, Harvard Medical School Medical Oncologist, Dana Farber Cancer Institute, Cambridge, Massachusetts You've probably heard about the human genome, but what about the human proteome? That's the entire set of human proteins that our genes make. Proteins control nearly every function of our bodies, and they play a role in most diseases. Scientists have been studying proteins for years, but now new technologies are allowing them to identify and categorize proteins more quickly. In this hour, we'll take a look a the science of proteomics and what it might mean for drug development.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

NPR thanks our sponsors

Become an NPR sponsor

Support comes from